Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Symptoms of barotrauma | |||||
RCT 3-armed trial |
150 adults |
Proportion of people with symptoms of barotrauma (ear pain, blockage, hearing loss, dizziness/vertigo, and tinnitus; assessed by post-flight questionnaire)
14/41 (34%) with pseudoephedrine 120 mg 29/41 (71%) with placebo |
RR 0.48 95% CI 0.29 to 0.67 |
Moderate effect size | pseudoephedrine |
RCT |
190 adults |
Proportion of people reporting ear pain (assessed by post-flight questionnaire)
25/96 (26%) with pseudoephedrine 120 mg 43/94 (46%) with placebo |
P = 0.007 |
Effect size not calculated | pseudoephedrine |
RCT |
190 adults |
Proportion of people reporting hearing loss (assessed by post-flight questionnaire)
20/96 (21%) with pseudoephedrine 120 mg 38/94 (40%) with placebo |
P = 0.006 |
Effect size not calculated | pseudoephedrine |